GE HealthCare Technologies stock plunges 13.16 percent in rough market session

11 articles · Updated · MarketWatch · Apr 29

Shares closed at $59.49 on Wednesday, marking a second consecutive day of losses and trading 33.74% below the 52-week high of $89.77.
Trading volume surged to 23.4 million, far exceeding the 50-day average of 3.5 million, as the S&P 500 and Dow Jones also declined.
The sharp drop underscores broader market volatility, with GE HealthCare’s stock significantly underperforming major indices during this session.

Is GE HealthCare's stock plunge a temporary crisis or a sign of deeper problems in the global medtech industry?

With its stock down over 30% from its peak, is GE HealthCare now the most undervalued company in medtech?

How does the Q1 earnings miss impact GE HealthCare's ability to fund its $2.3 billion Intelerad acquisition?

Can GE HealthCare's pivot to AI and software overcome its current profitability and supply chain emergencies?

What specific steps can GE HealthCare take to protect its operations from the ongoing Operation Epic Fury disruptions?

Will investor backlash against medtech accelerate the industry's shift from equipment sales to subscription models?